Last updated: 2026-09-18 19:38:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Alamar Biosciences, Inc. (ALMR) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $34.09, with a market capitalization of $2.04B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $18.85 to $38.54. This page covers its latest market performance, valuation, price trends and company information.
$2.04B | |
$31.76 | |
$38.54 | |
$18.85 | |
$32.01 | |
1.45M | |
352.44K | |
-- | |
$38.54 | |
$18.85 | |
-- | |
-- |
Alamar Biosciences, Inc. (ALMR) is currently trading at $34.09 as of 2026-09-18 19:22:08, up 6.48% ($2.08) from the previous close of $32.01
During today's regular trading session, ALMR has traded between $18.85 and $38.54, with a trading volume of 1.45M shares. The current price is near the upper end of today's range.
Over the past seven days, Alamar Biosciences, Inc. (ALMR) moved from $28.96 to $34.09, representing a gain of 17.70% ($5.13).
The stock traded between $27.25 and $37.65 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 390.45 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 77.4%
ALMR is currently trading at $34.09, placing it 77.4% of the way from its 52-week low of $18.85 to its 52-week high of $38.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Alamar Biosciences, Inc. (ALMR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.